Abstract
Conclusions: [F-18] exendin-4 showed promise as a tracer for clinical imaging of pancreatic beta cells, due to its high specific uptake in native beta cells and its concomitant low kidney radioactivity uptake.
Original language | Undefined/Unknown |
---|---|
Pages (from-to) | – |
Number of pages | 11 |
Journal | EJNMMI Research |
Volume | 6 |
DOIs | |
Publication status | Published - 2016 |
MoE publication type | A1 Journal article-refereed |
Keywords
- beta cell
- Exendin
- F-18
- Pancreas
- PET